• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物通过AMPK途径下调糖尿病心房肌细胞中的连接蛋白43和连接蛋白40。

Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway.

作者信息

Yang Fan, Liu Huan-Huan, Zhang Lei, Zhang Xiao-Lu, Zhang Jie, Li Feng, Zhao Ning, Zhang Zhi-Yuan, Kong Qi, Liu Xiao-Yu, Wu Ying, Yu Zhi-Ming, Qian Ling-Ling, Wang Ru-Xing

机构信息

Department of Cardiology, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214023, People's Republic of China.

Wuxi School of Medicine, Jiangnan University, Wuxi, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2023 Oct 2;16:3045-3056. doi: 10.2147/DMSO.S419189. eCollection 2023.

DOI:10.2147/DMSO.S419189
PMID:37810573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10557968/
Abstract

PURPOSE

Diabetes mellitus is an independent risk factor for atrial fibrillation (AF), which may be related to accumulation of advanced glycation end products (AGEs). However, the mechanisms involved are not completely clear. Abnormality of gap junction proteins, especially connexin 43 (Cx43) and connexin 40 (Cx40) in atrial myocytes, is an important cause of increased susceptibility of AF. The aim of our work is to investigate the mechanism of dysregulated Cx43 and Cx40 in atrial myocytes of diabetic rats.

METHODS

We established a type 1 diabetic rat model by intraperitoneal injection of streptozotocin. HL-1 cells and primary rat atrial myocytes were treated with AGEs in vitro. Using Western blotting, immunofluorescence staining, immunohistochemistry, and lucifer yellow diffusion measurements, we investigated dysregulation of Cx43 and Cx40 and its mechanism in atrial myocytes of diabetic rats.

RESULTS

Accumulation of AGEs was found in diabetic rats. The expression of Cx43 and Cx40 was reduced in the atrium of diabetic rats, accompanied by the decrease of phosphorylated Adenosine 5'-monophosphate-activated protein kinase (p-AMPK). Similar results were found in cultured HL-1 cells and primary rat atrial myocytes, suggesting a role of AGEs on gap junction proteins. An AMPK agonist, 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR), reversed the down-regulated Cx43 expression induced by AGEs stimulation. More importantly, lucifer yellow diffusion assay showed that AGEs significantly affected gap junctional function, and these changes were reversed by AICAR.

CONCLUSION

Thus, we conclude that AGEs cause dysregulation of Cx43 and Cx40 in diabetic atria via the AMPK pathway, thereby leading to gap junction dysfunction, which may contribute to the increased AF susceptibility in diabetes.

摘要

目的

糖尿病是心房颤动(AF)的独立危险因素,这可能与晚期糖基化终产物(AGEs)的积累有关。然而,其中涉及的机制尚不完全清楚。心房肌细胞中缝隙连接蛋白异常,尤其是连接蛋白43(Cx43)和连接蛋白40(Cx40),是AF易感性增加的重要原因。我们研究的目的是探讨糖尿病大鼠心房肌细胞中Cx43和Cx40失调的机制。

方法

通过腹腔注射链脲佐菌素建立1型糖尿病大鼠模型。HL-1细胞和原代大鼠心房肌细胞在体外接受AGEs处理。使用蛋白质免疫印迹法、免疫荧光染色、免疫组织化学和荧光黄扩散测量,我们研究了糖尿病大鼠心房肌细胞中Cx43和Cx40的失调及其机制。

结果

在糖尿病大鼠中发现了AGEs的积累。糖尿病大鼠心房中Cx43和Cx40的表达降低,同时磷酸化腺苷5'-单磷酸激活蛋白激酶(p-AMPK)减少。在培养的HL-1细胞和原代大鼠心房肌细胞中也发现了类似结果,提示AGEs对缝隙连接蛋白有作用。一种AMPK激动剂,5-氨基咪唑-4-甲酰胺核苷(AICAR),逆转了AGEs刺激诱导的Cx43表达下调。更重要的是,荧光黄扩散试验表明AGEs显著影响缝隙连接功能,而这些变化被AICAR逆转。

结论

因此,我们得出结论,AGEs通过AMPK途径导致糖尿病心房中Cx43和Cx40失调,从而导致缝隙连接功能障碍,这可能导致糖尿病中AF易感性增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/b5543aca9c17/DMSO-16-3045-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/e9a6dc0679a4/DMSO-16-3045-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/b7f63611ecab/DMSO-16-3045-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/a372cef8e98f/DMSO-16-3045-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/370d017fef32/DMSO-16-3045-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/3b2a8e67c549/DMSO-16-3045-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/95b7b8acd87f/DMSO-16-3045-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/b5543aca9c17/DMSO-16-3045-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/e9a6dc0679a4/DMSO-16-3045-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/b7f63611ecab/DMSO-16-3045-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/a372cef8e98f/DMSO-16-3045-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/370d017fef32/DMSO-16-3045-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/3b2a8e67c549/DMSO-16-3045-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/95b7b8acd87f/DMSO-16-3045-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/10557968/b5543aca9c17/DMSO-16-3045-g0007.jpg

相似文献

1
Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway.晚期糖基化终末产物通过AMPK途径下调糖尿病心房肌细胞中的连接蛋白43和连接蛋白40。
Diabetes Metab Syndr Obes. 2023 Oct 2;16:3045-3056. doi: 10.2147/DMSO.S419189. eCollection 2023.
2
Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat.山羊心房颤动稳定化过程中的缝隙连接重塑
Cardiovasc Res. 2000 Jun;46(3):476-86. doi: 10.1016/s0008-6363(00)00026-2.
3
Relating specific connexin co-expression ratio to connexon composition and gap junction function.将特定连接蛋白共表达比例与连接子组成及间隙连接功能相关联。
J Mol Cell Cardiol. 2015 Dec;89(Pt B):195-202. doi: 10.1016/j.yjmcc.2015.11.008. Epub 2015 Nov 6.
4
Connexin40 and connexin43 determine gating properties of atrial gap junction channels.连接蛋白 40 和连接蛋白 43 决定了心房缝隙连接通道的门控特性。
J Mol Cell Cardiol. 2010 Jan;48(1):238-45. doi: 10.1016/j.yjmcc.2009.05.014. Epub 2009 May 30.
5
Connexin expression in cultured neonatal rat myocytes reflects the pattern of the intact ventricle.培养的新生大鼠心肌细胞中连接蛋白的表达反映了完整心室的模式。
Cardiovasc Res. 1999 Nov;44(2):370-80. doi: 10.1016/s0008-6363(99)00196-0.
6
Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway.晚期糖基化终产物损害糖尿病心肌病中的 Na⁺/K⁺-ATP 酶活性:腺苷单磷酸激活蛋白激酶/沉默调节蛋白 1 通路的作用。
Clin Exp Pharmacol Physiol. 2014 Feb;41(2):127-33. doi: 10.1111/1440-1681.12194.
7
Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40.心脏间隙连接蛋白连接蛋白43和连接蛋白40的药理学调节及差异调控
Biol Cell. 2002 Nov;94(7-8):409-22. doi: 10.1016/s0248-4900(02)00018-7.
8
Connexin 43 is involved in the sympathetic atrial fibrillation in canine and canine atrial myocytes.连接蛋白43与犬类及犬类心房肌细胞的交感神经性心房颤动有关。
Anatol J Cardiol. 2017 Jul;18(1):3-9. doi: 10.14744/AnatolJCardiol.2017.7602. Epub 2017 May 24.
9
Relationship between connexin expression and gap-junction resistivity in human atrial myocardium.缝隙连接蛋白表达与人心房肌缝隙连接电阻之间的关系。
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):321-9. doi: 10.1161/CIRCEP.113.000606. Epub 2014 Mar 7.
10
Interaction of KCNA5, CX43, and CX40 proteins in the atrial muscle of patients with atrial fibrillation.KCNA5、CX43 和 CX40 蛋白在心房颤动患者心房肌中的相互作用。
Cell Biol Int. 2022 Nov;46(11):1834-1840. doi: 10.1002/cbin.11864. Epub 2022 Jul 23.

引用本文的文献

1
Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies.糖尿病中的心房颤动:发病机制与靶向性节律控制策略
Curr Issues Mol Biol. 2025 Jul 17;47(7):559. doi: 10.3390/cimb47070559.
2
Identifying and establishing the critical elements of a human cardiac in-vitro model for studying type-II diabetes.识别并确立用于研究II型糖尿病的人体心脏体外模型的关键要素。
Discov Appl Sci. 2025;7(7):788. doi: 10.1007/s42452-025-07442-y. Epub 2025 Jul 15.
3
Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights.

本文引用的文献

1
Lipoxin and glycation in SREBP signaling: Insight into diabetic cardiomyopathy and associated lipotoxicity.脂氧素与SREBP信号通路中的糖基化:对糖尿病性心肌病及相关脂毒性的见解。
Prostaglandins Other Lipid Mediat. 2023 Feb;164:106698. doi: 10.1016/j.prostaglandins.2022.106698. Epub 2022 Nov 13.
2
Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes-related ventricular arrhythmogenesis.晚期糖基化终产物调节右心室流出道心肌细胞的电生理重构:糖尿病相关室性心律失常发生的新靶点。
Physiol Rep. 2022 Nov;10(21):e15499. doi: 10.14814/phy2.15499.
3
曲格列汀治疗 2 型糖尿病的临床疗效及安全性评价
Vasc Health Risk Manag. 2024 Jun 21;20:255-288. doi: 10.2147/VHRM.S391808. eCollection 2024.
4
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications.心房颤动中的代谢重塑:表现、机制及临床意义。
Nat Rev Cardiol. 2024 Oct;21(10):682-700. doi: 10.1038/s41569-024-01038-6. Epub 2024 May 30.
Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetes.
晚期糖基化终产物与 1 型糖尿病年轻患者的糖尿病神经病变有关。
Front Endocrinol (Lausanne). 2022 Oct 11;13:891442. doi: 10.3389/fendo.2022.891442. eCollection 2022.
4
Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice.晚期糖基化终产物诱导糖尿病小鼠心房肌细胞衰老并增加心房颤动易感性。
Aging Cell. 2022 Dec;21(12):e13734. doi: 10.1111/acel.13734. Epub 2022 Oct 24.
5
Habitual intake of dietary methylglyoxal is associated with less low-grade inflammation: the Maastricht Study.习惯性摄入膳食甲基乙二醛与低度炎症减少有关:马斯特里赫特研究。
Am J Clin Nutr. 2022 Dec 19;116(6):1715-1728. doi: 10.1093/ajcn/nqac195.
6
Promotion of tumor progression induced by continuous low-dose administration of antineoplastic agent gemcitabine or gemcitabine combined with cisplatin.连续低剂量给予抗瘤药物吉西他滨或吉西他滨联合顺铂诱导肿瘤进展的促进作用。
Life Sci. 2022 Oct 1;306:120826. doi: 10.1016/j.lfs.2022.120826. Epub 2022 Jul 21.
7
Glucose fluctuation promotes cardiomyocyte apoptosis by triggering endoplasmic reticulum (ER) stress signaling pathway and .葡萄糖波动通过触发内质网(ER)应激信号通路促进心肌细胞凋亡。
Bioengineered. 2022 May;13(5):13739-13751. doi: 10.1080/21655979.2022.2080413.
8
Glucose Fluctuations Aggravate Myocardial Fibrosis the Nuclear Factor-κB-Mediated Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation.血糖波动加剧心肌纤维化:核因子-κB介导的核苷酸结合寡聚化结构域样受体蛋白3炎性小体激活
Front Cardiovasc Med. 2022 May 3;9:748183. doi: 10.3389/fcvm.2022.748183. eCollection 2022.
9
Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.高级糖基化终产物(AGEs):形成、化学、分类、受体以及与 AGEs 相关的疾病。
Cells. 2022 Apr 12;11(8):1312. doi: 10.3390/cells11081312.
10
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.糖基化终产物与糖尿病:机制与展望。
Biomolecules. 2022 Apr 4;12(4):542. doi: 10.3390/biom12040542.